Search Results - "Beavo, Joseph A."
-
1
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
Published in Pharmacological reviews (01-09-2006)“…Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP, by controlling their rates…”
Get full text
Journal Article -
2
Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy
Published in The Journal of pathology (01-09-2012)“…Duchenne muscular dystrophy (DMD) is the most common form of muscular dystrophy caused by mutations in the dystrophin gene. Loss of dystrophin initiates a…”
Get full text
Journal Article -
3
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
Published in Proceedings of the National Academy of Sciences - PNAS (02-11-2010)“…Duchenne muscular dystrophy (DMD) is a progressive and fatal genetic disorder of muscle degeneration. Patients with DMD lack expression of the protein…”
Get full text
Journal Article -
4
The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland
Published in Molecular pharmacology (01-04-2011)“…The functions of the phosphodiesterase 8B (PDE8) family of phosphodiesterases have been largely unexplored because of the unavailability of selective…”
Get more information
Journal Article -
5
Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis
Published in Proceedings of the National Academy of Sciences - PNAS (02-09-2014)“…Conflicting results have been reported for the roles of cGMP and cGMP-dependent protein kinase I (cGKI) in various pathological conditions leading to cardiac…”
Get full text
Journal Article -
6
Cardiac hypertrophy is not amplified by deletion of cGMP-dependent protein kinase I in cardiomyocytes
Published in Proceedings of the National Academy of Sciences - PNAS (23-03-2010)“…It has been suggested that cGMP kinase I (cGKI) dampens cardiac hypertrophy. We have compared the effect of isoproterenol (ISO) and transverse aortic…”
Get full text
Journal Article -
7
Role of Ca2+/Calmodulin–Stimulated Cyclic Nucleotide Phosphodiesterase 1 in Mediating Cardiomyocyte Hypertrophy
Published in Circulation research (06-11-2009)“…RATIONALE:Cyclic nucleotide phosphodiesterases (PDEs) through the degradation of cGMP play critical roles in maintaining cardiomyocyte homeostasis…”
Get full text
Journal Article -
8
Cyclic GMP Phosphodiesterases and Regulation of Smooth Muscle Function
Published in Circulation research (22-08-2003)“…ABSTRACT—Cyclic GMP (cGMP) made in response to atrial natriuretic peptide (ANP) or nitric oxide (NO) is an important regulator of short-term changes in smooth…”
Get full text
Journal Article -
9
Differential Regulation of Endothelial Cell Permeability by cGMP via Phosphodiesterases 2 and 3
Published in Circulation research (12-10-2007)“…Endothelial barrier dysfunction leading to increased permeability and vascular leakage is an underlying cause of several pathological conditions, including…”
Get full text
Journal Article -
10
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A
Published in Proceedings of the National Academy of Sciences - PNAS (26-12-2006)“…Leydig cells produce testosterone in the testes under the pulsatile control of pituitary luteinizing hormone (LH). cAMP is the intracellular messenger for LH…”
Get full text
Journal Article -
11
Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions
Published in Current opinion in cell biology (01-04-2000)“…The past eighteen months have provided much progress in the cyclic nucleotide phosphodiesterase (PDE) field. Six new phosphodiesterase genes have been…”
Get full text
Journal Article -
12
Hydrolysis Products of cAMP Analogs Cause Transformation of Trypanosoma Brucei from Slender to Stumpy-Like Forms
Published in Proceedings of the National Academy of Sciences - PNAS (12-12-2006)“…African sleeping sickness is a disease caused by Trypanosoma brucei. T. brucei proliferate rapidly in the mammalian bloodstream as long, slender forms, but at…”
Get full text
Journal Article -
13
Phosphodiesterase-8A binds to and regulates Raf-1 kinase
Published in Proceedings of the National Academy of Sciences - PNAS (16-04-2013)“…V-raf-1 murine leukemia viral oncogene homolog 1 (Raf-1) is a key activator of the ERK pathway and is a target for cross-regulation of this pathway by the cAMP…”
Get full text
Journal Article -
14
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages
Published in Proceedings of the National Academy of Sciences - PNAS (22-12-2009)“…Macrophages are central mediators of the innate immune system that can be differentiated from monocytes upon exposure to cytokines. While increased cyclic…”
Get full text
Journal Article -
15
A yeast-based chemical screen identifies a PDE inhibitor that elevates steroidogenesis in mouse Leydig cells via PDE8 and PDE4 inhibition
Published in PloS one (14-08-2013)“…A cell-based high-throughput screen (HTS) was developed to detect phosphodiesterase 8 (PDE8) and PDE4/8 combination inhibitors. By replacing the…”
Get full text
Journal Article -
16
The Two GAF Domains in Phosphodiesterase 2A Have Distinct Roles in Dimerization and in cGMP Binding
Published in Proceedings of the National Academy of Sciences - PNAS (01-10-2002)“…Cyclic nucleotide phosphodiesterases (PDEs) regulate all pathways that use cGMP or cAMP as a second messenger. Five of the 11 PDE families have regulatory…”
Get full text
Journal Article -
17
The Structure of the GAF A Domain from Phosphodiesterase 6C Reveals Determinants of cGMP Binding, a Conserved Binding Surface, and a Large cGMP-dependent Conformational Change
Published in The Journal of biological chemistry (19-09-2008)“…The photoreceptor phosphodiesterase (PDE6) regulates the intracellular levels of the second messenger cGMP in the outer segments of cone and rod photoreceptor…”
Get full text
Journal Article -
18
Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells
Published in The Journal of biological chemistry (01-02-2002)“…Nitric oxide and endogenous nitrovasodilators regulate smooth muscle tone by elevation of cGMP and activation of cyclic GMP-dependent protein kinase (PKG). The…”
Get full text
Journal Article -
19
Isolation and Characterization of a Dual-Substrate Phosphodiesterase Gene Family: PDE10A
Published in Proceedings of the National Academy of Sciences - PNAS (08-06-1999)“…We report here the cloning, expression, and characterization of a dual-substrate, cAMP and cGMP, cyclic nucleotide phosphodiesterase (PDE) from mouse. This PDE…”
Get full text
Journal Article -
20
Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator–Activated Receptor-γ–Independent Mechanism in Human Arterial Smooth Muscle Cells and Macrophages
Published in Diabetes (New York, N.Y.) (01-04-2007)“…Rosiglitazone Inhibits Acyl-CoA Synthetase Activity and Fatty Acid Partitioning to Diacylglycerol and Triacylglycerol via a Peroxisome Proliferator–Activated…”
Get full text
Journal Article